A subset of PEComas, the TFE3 translocation-associated PEComa [22], lack TSC mutation which may lead to hypothetical ineffectiveness of mTOR inhibitor therapy. The gene discussed is MTOR; the disease is neoplasm with perivascular epithelioid cell differentiation.